Neuropsychopharmacology
- Anxiety and depression in emerging adults: The STAND program as a model of scalable screening and intervention11 months ago
- Maternal separation disrupts noradrenergic control of adult coping behaviors11 months ago
- Myelination across the autism spectrum: therapeutic targeting of the oligodendrocyte lineage and myelination defects11 months ago
- Targeting GPR3 as a novel approach for nicotine cessation therapeutic development11 months ago
- Connectome-based encoding of subjective drug responses to acute oral methamphetamine11 months ago
- For those with schizophrenia, does cannabidiol make cannabis use safer?11 months ago
- Leveraging high-resolution brain imaging and (epi)genomic approaches to improve women’s mental health11 months ago
Journal of Psychopharmacology
- Ketamine for refractory depression: Save the best for last?2 years ago
- Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response2 years ago
- Autonomic nervous system activity correlates with peak experiences induced by DMT and predicts increases in well-being2 years ago
- A Phase 1 single ascending dose study of pure oral harmine in healthy volunteers2 years ago
- Less is more? A review of psilocybin microdosing2 years ago
- The relationship between Parkinson’s disease and sexual hyperactivity secondary to drug treatment: A systematic review2 years ago
- Antipsychotic medication in people with intellectual disability and schizophrenia: A 25-year updated systematic review and cross-sectional study2 years ago
European Neuropsychopharmacology
- From erectile dysfunction to dementia: A new role for sildenafil2 years ago
- The myth of minimum effective dose in antipsychotic treatment for patients with remitted psychosis2 years ago
- GLP-1 agonists and risk of suicidal thoughts and behaviours: Confound by indication once again? A narrative review2 years ago
- Treatment or enhancement? The controversial role of medication in personality disorders2 years ago
- Ensuring safety in cannabinoid prescriptions: A call for critical assessment2 years ago
- Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition2 years ago
- Childhood maltreatment: A call for a standardised definition and applied framework2 years ago